Conferences Oligomerix is attending in 2026
Oligomerix is listed at 2 conferences on Tnuki's calendar in 2026: SfN 2026 (on the program) and CTAD 2026 (on the program). Oligomerix develops small-molecule therapeutics targeting tau oligomers for Alzheimer’s disease and other neurodegenerative disorders. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
Neuroscience 2026 (SfN Annual Meeting)World’s largest neuroscience gatheringOfficial site |
Washington, DC ~21k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 2 posters Attendee mix: Mostly academic; neuroscience PIs, postdocs and students, some industry neuroscientists
Attending
|
Open the guide Search and filter attendees |
19th Clinical Trials on Alzheimer’s Disease (CTAD) ConferenceAlzheimer’s trial sponsors & biomarker vendorsOfficial site |
Boston, MA ~1.7k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster Attendee mix: Evenly mixed industry & academia; Alzheimer’s trial sponsors, academic trialists, CRO, eCOA and biomarker teams
Attending
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Oligomerix’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Oligomerix
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!